文献速递银屑病与炎症性皮肤病湿疹皮炎与荨麻疹毛发、甲与色素性疾病

基于词嵌入的机器学习方法预测免疫介导性皮肤疾病的药物重定位

Drug Repurposing Prediction for Immune-Mediated Cutaneous Diseases using a Word-Embedding-Based Machine Learning Approach.
PubMed 文献 · J Invest Dermatol · 2018-10-17

聚焦银屑病,研究证实了已知有效药物并识别出潜在候选药物,且预测候选药物的靶点在大型RNA测序队列的银屑病皮损差异表达基因中显著富集。

要点

  • 词嵌入机器学习模型在九种皮肤疾病和八种其他免疫介导性疾病中交叉验证平均AUC为0.93。
  • 聚焦银屑病,模型证实了已知有效药物并识别出用于其他疾病的潜在候选药物。
  • 预测候选药物的靶点在大型RNA测序队列的银屑病皮损差异表达基因中显著富集。

核心结论

  • 该算法不能用于确定临床疗效,但为免疫介导性皮肤疾病的药物重定位提供了一种候选药物建议方法。

研究设计与样本

  • 模型分别在九种皮肤疾病(包括银屑病、特应性皮炎和斑秃)和八种其他免疫介导性疾病上训练。

主要发现

  • 交叉验证中平均受试者工作特征曲线下面积为0.93。
  • 聚焦银屑病,模型证实了已知有效药物并识别出用于其他疾病的潜在候选药物。
  • 预测候选药物的靶点在大型RNA测序队列的银屑病皮损差异表达基因中显著富集。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 该算法不能用于确定临床疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Immune-mediated diseases affect more than 20% of the population, and many autoimmune diseases affect the skin. Drug repurposing (or repositioning) is a cost-effective approach for finding drugs that can be used to treat diseases for which they are currently not prescribed. We implemented an efficient bioinformatics approach using word embedding to summarize drug information from more than 20 million articles and applied machine learning to model the drug-disease relationship. We trained our drug repurposing approach separately on nine cutaneous diseases (including psoriasis, atopic dermatitis, and alopecia areata) and eight other immune-mediated diseases and obtained a mean area under the receiver operating characteristic of 0.93 in cross-validation. Focusing in particular on psoriasis, a chronic inflammatory condition of skin that affects more than 100 million people worldwide, we were able to confirm drugs that are known to be effective for psoriasis and to identify potential candidates used to treat other diseases. Furthermore, the targets of drug candidates predicted by our approach were significantly enriched among genes differentially expressed in psoriatic lesional skin from a large-scale RNA sequencing cohort. Although our algorithm cannot be used to determine clinical efficacy, our work provides an approach for suggesting drugs for repurposing to immune-mediated cutaneous diseases.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Patrick MT, Raja K, Miller K, et al. Drug Repurposing Prediction for Immune-Mediated Cutaneous Diseases using a Word-Embedding-Based Machine Learning Approach. J Invest Dermatol. 2018. PMID: 30342048. doi:10.1016/j.jid.2018.09.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。